About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us
> Real-time Quotes & News

Real-time Quotes

Product
Bid
Ask
High
Low
Previous Close
*The above quotes are for reference only

Real-time News

2026-11-09

China's State Administration for Market Regulation (SAMR) has opened a public consultation on two draft risk-control guidelines for infant formula manufacturers: a Clean-in-Place (CIP) risk-control guideline (draft for comment) and a plasticizer risk

China's State Administration for Market Regulation (SAMR) has opened a public consultation on two draft risk-control guidelines for infant formula manufacturers: a Clean-in-Place (CIP) risk-control guideline (draft for comment) and a plasticizer risk-control guideline (draft for comment).
2026-11-09

The State Administration for Market Regulation has publicly solicited opinions on the "Guidelines for Risk Prevention and Control of Clean-in-Place (CIP) in Infant Formula Milk Powder Manufacturers (Draft for Comments)" and the "Guidelines for Risk P

The State Administration for Market Regulation has publicly solicited opinions on the "Guidelines for Risk Prevention and Control of Clean-in-Place (CIP) in Infant Formula Milk Powder Manufacturers (Draft for Comments)" and the "Guidelines for Risk Prevention and Control of Plasticizers in Infant Formula Milk Powder Manufacturers (Draft for Comments)".
2026-11-09

1. Elon Musk adjusts production plans for his Texas factory; Cybertruck production will shift to Cybercab. 2. Maserati will partner with the Zunjie to promote localized production. 3. China Passenger Car Association (CPCA): September pure electric

1. Elon Musk adjusts production plans for his Texas factory; Cybertruck production will shift to Cybercab. 2. Maserati will partner with the Zunjie to promote localized production. 3. China Passenger Car Association (CPCA): September pure electric vehicle sales reached approximately 760,000 units, a year-on-year decrease of 9.3%. 4. CPCA: November presents structural opportunities for new energy vehicles and mid-to-low-end gasoline vehicles. 5. CPCA: October retail sales of gasoline vehicles decreased by 45% year-on-year, with pure gasoline vehicles decreasing by 51% year-on-year. 6. BYD's Li Yunfei: BYD's full-year sales are expected to see slight growth, with even higher growth overseas. 7. JAC Motors: October sales reached 32,296 units, a year-on-year increase of 2.48%. 8. The UK is reportedly considering lowering its 2030 zero-emission vehicle sales target to approximately 60%. 9. LG's vehicle communication control module has become the first to receive TÜV Rheinland ASILD certification and has been adopted by the Genesis GV90. 10. Rolls-Royce's deliveries in the first nine months of this year fell by 12.4% year-on-year, making it the brand with the largest decline under the BMW Group. 11. The US NHTSA is pushing forward with reforms to its vehicle recall mechanism, with OTA upgrades becoming a core path to improve repair rates.
2026-11-09

Shanghai municipal Food and Drug Safety Committee issued its 15th Five-Year plan to ensure drug safety and promote high-quality pharmaceutical development, calling for targeted supervision of priority fields and products. It mandates establishment of

Shanghai municipal Food and Drug Safety Committee issued its 15th Five-Year plan to ensure drug safety and promote high-quality pharmaceutical development, calling for targeted supervision of priority fields and products. It mandates establishment of accountability and risk‑sharing mechanisms for contract manufacturing and enforcement of quality‑and‑safety responsibilities defined in contract manufacturing agreements. The plan orders intensified on-site inspections at vaccine producers and full-coverage targeted supervision for vaccines, blood products, advanced therapy drugs, sterile pharmaceuticals, special-category medicines and products with segmented production processes, with emphasis on data reliability, sterility assurance, deviation control and change management. It also tightens oversight of implantable and sterile medical devices and devices selected via centralized procurement, requires one-product/one-policy regulatory plans for innovative devices, and steps up checks on procurement of critical raw materials, finished‑product testing and release. Separately, Shanghai will launch a production quality-management upgrade for cosmetics manufacturers, prioritizing special-use cosmetics and products using new raw materials and strengthening raw‑material controls.
2026-11-09

South Korea’s Trade, Industry and Energy Minister Kim Jung-kwan said Seoul will monitor the impact of the US midterm elections and respond flexibly to changes in US policy and Congress. He said AI investment is likely to continue expanding structural

South Korea’s Trade, Industry and Energy Minister Kim Jung-kwan said Seoul will monitor the impact of the US midterm elections and respond flexibly to changes in US policy and Congress. He said AI investment is likely to continue expanding structurally, is unlikely to be derailed by short-term volatility, and that current conditions present a favorable time to invest; Seoul will avoid overreacting to near-term developments.
2026-11-09

South Korea's vice minister for science and technology said Seoul is monitoring the possibility that US AI data center investment could shift to South Korea.

South Korea's vice minister for science and technology said Seoul is monitoring the possibility that US AI data center investment could shift to South Korea.
Previous 1 ... 156 157 158 159 160 ... 251 Next
Real-time Quotes
Real-time News
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2026 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.